TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Avansor Pharma Oy
Closing information (x1000 NOK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
18,000
|
12,255
|
14,333 |
| Financial expenses |
82
|
48
|
9 |
| Earnings before taxes |
7,078
|
4,024
|
3,375 |
| Total assets |
35,446
|
32,243
|
26,132 |
| Current assets |
16,246
|
5,554
|
7,438 |
| Current liabilities |
5,007
|
3,307
|
2,416 |
| Equity capital |
27,713
|
26,077
|
23,716 |
| - share capital |
291
|
306
|
290 |
| Employees (average) | 3 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
78.2%
|
80.9%
|
90.8% |
| Turnover per employee | 4,778 | ||
| Profit as a percentage of turnover |
39.3%
|
32.8%
|
23.5% |
| Return on assets (ROA) |
20.2%
|
12.6%
|
12.9% |
| Current ratio |
324.5%
|
167.9%
|
307.9% |
| Return on equity (ROE) |
25.5%
|
15.4%
|
14.2% |
| Change turnover |
6,351
|
-2,887 | |
| Change turnover % |
55%
|
-19% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.